A scoping review: the impact of nutritional status on the efficacy, effectiveness, and immunogenicity of COVID-19 vaccines

Oktaria, Vicka and Wiratama, Bayu Satria and Riyanto, Slamet and Purbaningrum, Ratih Puspitaningtyas and Kusuma, Citra Widya and Saraswati, Lintang Dian and Widyaningsih, Vitri and Febrinasari, Ratih Puspita and Probandari, Ari and Ahmad, Riris Andono (2025) A scoping review: the impact of nutritional status on the efficacy, effectiveness, and immunogenicity of COVID-19 vaccines. Tropical Diseases, Travel Medicine and Vaccines, 11 (1): 21. ISSN 20550936

[thumbnail of A scoping review the impact of nutritional.pdf] Text
A scoping review the impact of nutritional.pdf - Published Version
Restricted to Registered users only
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (1MB) | Request a copy

Abstract

Background: Vaccination is one of the most effective strategies in mitigating the severity of SARS-CoV-2 infection. While a connection between poor nutritional status and diminished immune responses to vaccination has been noted, comprehensive reviews elucidating this association have been scarce. To address this gap, we conducted a scoping review to characterise the relationship between nutritional status (specifically, body mass index (BMI) or micronutrient deficiencies) and the responses to COVID-19 vaccination, encompassing efficacy, effectiveness, and immunogenicity. Method: We searched PubMed, OVID-Medline, Scopus, Cochrane Covid Register, LitCovid, and WHO COVID-19 research databases for studies that reported the association between nutritional status and responses to the COVID-19 vaccines (published between December 20, 2019, and December 30, 2023). Two reviewers independently screened the articles, and disagreements were resolved through consensus or by a third reviewer. Results: Seventy-three out of 1,853 identified articles were included in this review, predominantly featuring cohort designs (72). Among these studies, 63 reported BMI, 30 focused on micronutrients (specifically vitamin D, selenium, iron, zinc), and 6 examined both. Most studies (84) focused on vaccine immunogenicity. The most frequently studied vaccines were BNT162b2 (Pfizer, 74), ChAdOx (AstraZeneca, 23), and mRNA-1273 (Moderna, 14). High BMI significantly reduced COVID-19 vaccine immunogenicity in 23 studies, while adequate vitamin D was associated with increased vaccine response in seven studies. Conclusion: Overnutrition and micronutrient deficiencies (vitamin D, iron, selenium and zinc) have been observed to attenuate the potency of COVID-19 vaccines. Future strategies aimed at prioritizing vaccination in obese and overweight individuals, or enhancing their vaccine response, may involve identifying measures such as the provision of booster doses. Additionally, efforts should ensure micronutrient adequacy, including improving vitamin D status through strategies like increased sun exposure or supplementation, particularly for deficient individuals. © The Author(s) 2025.

Item Type: Article
Additional Information: Cited by: 1; All Open Access; Gold Open Access; Green Open Access
Uncontrolled Keywords: coronavac; covaxin; covilo; elasomeran; ibacovavec; SARS-CoV-2 vaccine; sputnik v vaccine; tozinameran; vaxzevria; body mass; comorbidity; coronavirus disease 2019; drug efficacy; drug potency; drug response; human; iron deficiency; nutritional deficiency; nutritional status; obesity; overnutrition; publication; Review; selenium deficiency; sun exposure; vaccine immunogenicity; vitamin D deficiency; zinc deficiency
Subjects: R Medicine > RB Biomedical Sciences
Divisions: Faculty of Medicine, Public Health and Nursing > Biomedical Sciences
Depositing User: Ani PURWANDARI
Date Deposited: 08 Apr 2026 07:22
Last Modified: 08 Apr 2026 07:22
URI: https://ir.lib.ugm.ac.id/id/eprint/26221

Actions (login required)

View Item
View Item